Pre-market
Loading markets…

Advertisement

Stocks

Why Apotex Health Corp stock plummeted yesterday

By Wealth Awesome -

This move is archived. Current quotes and coverage live on the stock page.

Stocks & ETFs:APTX.TO

Follow APTX

Photos provided by Pexels

A significant drop in stock value raises questions about Apotex Health Corp's market position.

Apotex Health Corp (APTX.TO) saw its stock price fall sharply yesterday, dropping by 9.20% to close at CA$33.27. This decline occurs amid recent activity and strategic developments within the company, signaling potential concerns for investors.

Advertisement

Apotex Health Corp

APTX.TO

Full stock page →

APTX.TO

Apotex Health Corp

Source:WealthAwesomeWealthAwesome
↑ $6.27 (23.28%)
92 day period
$26.96$33.28$39.61Jun 10Aug 17Oct 21

Market cap

$7.43B

52W high

$40.11

52W low

$26.01

1W change

+5.21%

Analyst Price Targets

Based on analyst covering APTX · as of Sep 23, 2026

📈

Wall Street analysts forecast APTX stock price to rise 27.3% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$41.37

+27.3% Upside

Previously C$41.23 on Sep 17, 2026

Current Price

C$32.50

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on APTX's historical volatility

HistoricalForecast68%95%
C$16.56C$23.83C$31.10C$38.38C$45.65C$52.93TodayJun 12Aug 18Oct 21Dec 3Jan 16Feb 28

30-Day Vol

46.1%

Annualized

90-Day Vol

45.8%

Annualized

Trend (90d)

-32.2%

Annualized drift

90d Mean

C$29.62

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$31.98C$27.28 – C$37.49
60 trading daysC$30.77C$24.58 – C$38.54
90 trading daysC$29.62C$22.48 – C$39.01

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Investors should keep a close eye on Apotex's performance and think about the implications of this recent stock decline, especially considering its strategic initiatives and current market conditions.

Apotex's stock fell by 9.20% yesterday

This decline represents a substantial loss in market value and reflects investor concerns amid ongoing strategic developments.

Bull case

Despite the recent drop, Apotex has demonstrated growth potential, reporting an 11% revenue increase in Canada and a strong adjusted EBITDA margin of 31% in its latest quarterly results.

Bear case

The significant decline in stock value raises red flags about investor confidence and may indicate underlying issues that need to be addressed, particularly given the company's negative profit margin.

Recent Performance Overview

Advertisement

Apotex Health Corp's stock fell significantly yesterday, closing at CA$33.27 after a 9.20% drop. This decline is noteworthy, especially considering the company's recent upsized secondary offering and positive quarterly results, which had previously boosted investor confidence.

Market Reactions and Future Outlook

The market's reaction to Apotex's stock decline suggests a cautious sentiment among investors. While the company has made progress in revenue growth and strategic transactions, the drop in stock price could point to underlying concerns that need attention. Investors should stay alert for any news or developments that could affect Apotex's future.

Implications for Investors

For those holding shares in Apotex, this recent decline may lead to a reevaluation of their positions. The company's negative profit margin and the significant drop in stock value highlight the need to stay informed about market conditions and company performance. As Apotex continues to pursue its growth strategy, investors should remain vigilant.

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: September 16, 2026
Last Updated: October 2, 2026

Core portfolio

Awesome Portfolio™

14.8% a year since 2017, against 9.7% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+14.8%

Awesome Portfolio™

+9.7%

S&P/TSX

+5.0 pp better a year

Total return

+254%

Awesome Portfolio™

+134%

S&P/TSX

+119 pp better than the TSX

2017-07-31 to 2026-09-29, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-29
-11.7%42.5%96.7%150.9%205.1%259.3%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement